Tagged: stem cell Toggle Comment Threads | Keyboard Shortcuts

  • Anouk Lorie 2:43 pm on October 18, 2015 Permalink
    Tags: , autologous bone marrow cell, BrainStorm Cell, israel stem cell ALS, ms, , , , stem cell, stem cell neurodegenerative disease, stem cells Ramot   

    BrainStorm Granted Patent For Stem Cell Treatment 

    BrianStormBrainStorm Cell Therapeutics, an Israeli developer of adult stem cell technologies for neurodegenerative diseases, has been granted a patent by the Israeli Patent Office for the company’s NurOwn Technology Platform. Founded in 2004 and now led by Chaim Lebovits, BrainStorm is developing treatments for Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig’s disease), Multiple Sclerosis (MS) and Parkinson’s Disease (PD).

  • Anouk Lorie 1:00 pm on July 27, 2014 Permalink
    Tags: $5million, , , brazilian ministry of health, , , stem cell, therapeutics   

    BrainStorm Cell Therapeutics To Receive $5M From Brazilian Health Ministry 

    BrainStorm Receives $800,000 Grant From Chief ScientistJuly 27, 2014 | The Israeli company BrainStorm Cell Therapeutics is expected to receive a $5 million grant from the Brazilian Ministry of Health. The funds will go towards conducting trials on its product in conjunction with the University of Sao Paolo, according to “Globes.” The company has yet to respond to the reports, which are not yet official. BrainStorm Cell Therapeutics specializes in developing stem cell therapies for the treatment of neurodegenerative diseases such as ALS (Lou Gehrig’s disease), multiple sclerosis, and Parkinson’s disease.

  • NoCamels Team 12:57 pm on December 25, 2012 Permalink | Reply
    Tags: , amit, itskovitz-eldor, stem cell,   

    Technion And AMIT Set Up Company For Stem Cell Technology 

    Technion And AMIT Set Up Company For Stem Cell Technology The Technion – Israel Institute of Technology, alongside the Alfred Mann Institute (AMIT) have founded a company aimed to commercialize stem cell technology developed over the past decade by Professor Joseph Itskovitz-Eldor of the Rappaport institute. The new company, named Accellta, will market technologies and methods which will assist commercial companies and research labs in cultivating stem cells quickly, efficiently and aconomically.

  • NoCamels Team 7:57 am on September 6, 2012 Permalink | Reply
    Tags: , , , stem cell,   

    Pfizer Interested In Commercializing Gamida Cell’s Cancer Treatment 

    Pfizer Interested In Commercializing Gamida Cell's Cancer TreatmentPharmaceutical giant Pfizer is in contact with Israeli companies Gamida Cell and TEVA, with intent of commercializing Gamida Cell’s StemEX, a treatments for lymphoma and leukemia (which is partially owned by TEVA). Israeli economics magazine Calcalist reports that if the deal goes through, Gamida cell will receive tens of millions of dollars in advance plus grants for milestones reached. Gamida Cell specializes in developing stem cell therapy projects.

  • NoCamels Team 1:20 pm on May 15, 2012 Permalink | Reply
    Tags: , , , , stem cell   

    ‘Gamida Cell’ Closes $10M For Stem Cell Treatment 

    Gamida - News Flash - IsraelIsraeli company Gamida Cell announced today that it has closed an internal financing round of $10 million from all major shareholders. According to the company, the financing will be used to support the global commercialization of the company’s lead cell therapy product, StemEx. The product is in development as an alternative therapeutic treatment for patients with blood cancers, such as leukemia and lymphoma who can be cured by bone marrow transplantation but do not have a matched bone marrow donor.

  • NoCamels Team 10:51 am on May 1, 2012 Permalink | Reply
    Tags: , , , , , stem cell   

    Merck Serono Signs 5 Year Agreement With ‘Kadimastem’ 

    Kadimastem - News Flash - IsraelKadimastem, an Israeli biotechnology company that develops human pluripotent stem cell-related products, announced the signing of a five year framework agreement with Merck Serono. The agreement concerns the use of Kadimastem’s drug-screening platform to discover new oral drugs for the treatment of the neurological disease Multiple Sclerosis (MS). The company is based in Nes-Ziona, Israel.

Compose new post
Next post/Next comment
Previous post/Previous comment
Show/Hide comments
Go to top
Go to login
Show/Hide help
shift + esc